Idhifa 50 mg/1
enasidenib mesylate · TABLET, FILM COATED · Celgene Corporation
No Recall History
Plain English
Idhifa is a tablet, film coated containing enasidenib mesylate at 50 mg/1, taken oral. Manufactured by Celgene Corporation.
Key Facts
- Brand Name
- Idhifa
- Generic Name
- enasidenib mesylate
- NDC Code (Product)
59572-705- Manufacturer
- Celgene Corporation
- Strength
- 50 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA209606
- Marketing Start
- 08/01/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Idhifa used for?
Idhifa contains enasidenib mesylate. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Idhifa a controlled substance?
Idhifa is not classified as a controlled substance by the DEA.
What is the generic name for Idhifa?
The generic name for Idhifa is enasidenib mesylate. There are no other listed brand versions of enasidenib mesylate.
What is the NDC code for Idhifa 50 mg/1?
The NDC (National Drug Code) for Idhifa 50 mg/1 is 59572-705, listed by Celgene Corporation.
Other Idhifa Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)